96209 ⎘
Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds; Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
Sub-classes:REAGENTS AND THEIR USE FOR MODULAR ENANTIODIVERGENT SYNTHESIS OF C-P BONDS
#2ALKYLENE OXIDE POLYMERIZATION USING PHOSPHONIUM CATALYSTS
#3NUCLEOTIDE CLEAVABLE LINKERS AND USES THEREOF
#4SMALL MOLECULE INHIBITORS OF NAV1.8 SODIUM CHANNELS FOR PAIN RELIEF
#5LIGNAN DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF
#6Synthesis Process of X-IPM, Stable Crystal Form and Application Thereof
#7SUBSTITUTED TETRAHYDROFURAN-2-CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS
#8DERIVATIVES OF KORORMICIN USEFUL AS ANTIBIOTICS
#9FUNCTIONALIZED CYCLIC ETHERS FOR LITHIUM-ION BATTERIES
#10NUCLEOTIDE CLEAVABLE LINKERS AND USES THEREOF
#11CARDIOPROTECTIVE LIPIDS AND METHODS OF USE
#12CARDIOPROTECTIVE LIPIDS AND METHODS OF USE
#13BUTYL-BRIDGED DIPHOSPHINE LIGANDS FOR ALKOXYCARBONYLATION
#14BIOINSPIRED LIPID DERIVATIVES AND USES THEREOF
#15Prodrugs derived from nicotinic acid and ribose
#16Solid support for synthesizing nucleic acid sequences and methods for making and using
#17REAGENTS AND THEIR USE FOR MODULAR ENANTIODIVERGENT SYNTHESIS OF C-P BONDS
#18Phosphoramidate derivatives of 5-fluoro-2′—deoxyuridine for use in the treatment of cancer
#19A NEW METHOD OF 18F LABELLING AND INTERMEDIATE SALTS
#20Reagents Useful for Synthesizing Rhodamine-Labeled Oligonucleotides
#21Cardioprotective Lipid and Method of Use
#22Nucleotide cleavable linkers and uses thereof
#23Derivatives of korormicin useful as antibiotics
#24INHIBITORS OF THE ENZYME ENOLASE FOR PRECISION ONCOLOGY
#25Cardiopathy-reducing phosphodiester lipids
#26Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
#27IONIC TAGS FOR SYNTHESIS OF OLIGORIBONUCLEOTIDES
#28BUTYL-BRIDGED DIPHOSPHINE LIGANDS FOR ALKOXYCARBONYLATION
#29Functionalized polymers
#30Cardiopathy-reducing phosphodiester lipids
#31TETRA-NUCLEAR NEUTRAL COPPER (I) COMPLEXES
#32Luminescent compound
#33Salts of prodrugs of piperazine and substituted piperidine antiviral agents
#34Derivatives of korormicin useful as antibiotics
#35Nucleotide cleavable linkers and uses thereof
#36Reagents useful for synthesizing rhodamine-labeled oligonucleotides
#37Limonene-based, non-halogenated flame retardants for polymeric applications
#38Resveratrol-based flame retardant materials
#39HYDROXY FORMAMIDE DERIVATIVES AND THEIR USE
#40SALTS OF PRODRUGS OF PIPERAZINE AND SUBSTITUTED PIPERIDINE ANTIVIRAL AGENTS
#41Arabitol and xylitol based flame retardants
#42Cardiopathy-reducing phosphodiester lipids
#43Prodrug compounds and their uses
#44Functionalized polymers
#45Simple preparation method for dialkoxypropyl methylphosphonate
#46Sorbitol, glucaric acid, and gluconic acid based flame-retardants
#47Prodrug and protected forms of 5-hydroxymethylfurfuranal (5-HMF) and its derivatives
#48Flame-retardant vanillin-derived monomers
#49Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
#50Novel Compounds
#51Limonene-based, non-halogenated flame retardants for polymeric applications
#52Arabitol and xylitol based flame retardants
#53Rare-earth complex polymer
#54SALTS OF PRODRUGS OF PIPERAZINE AND SUBSTITUTED PIPERIDINE ANTIVIRAL AGENTS
#55Derivatives of korormicin useful as antibiotics
#56Ionic tags for synthesis of oligoribonucleotides
#57Sorbitol, glucaric acid, and gluconic acid based flame-retardants
#58Lithium battery
#59Antibody-nanoparticle conjugates and methods for making and using such conjugates
#60Cross-linkable flame retardant materials
#61Resveratrol-based flame retardant materials
#62N-HYDROXYFORMAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THEM FOR USE AS BMP l, TLL1 AND/OR TLL2 INHIBITORS
#63Resveratrol-based flame retardant materials
#64Flame-retardant aconitic acid-derived monomers
#65Predictive biomarker for hypoxia-activated prodrug therapy
#66Lipid derivative in which hydrophilic polymer is bound through cyclic benzylidene acetal linker
#67Furan-containing flame retardant molecules
#68Cross-linkable flame retardant materials
#69Furan-containing flame retardant molecules
#70Cysteine-modifying substrate analogue inhibitors of ribose 5-phosphate isomerase for parasitic diseases, along with methods of their formation and use
#71Catalytic enantioselective synthesis of 2-aryl chromenes and related phosphoramidite ligands and catalyst compounds
#72Derivatives of korormicin useful as antibiotics
#73Process for the preparation of acylphosphanes
#74SALTS OF PRODRUGS OF PIPERAZINE AND SUBSTITUTED PIPERIDINE ANTIVIRAL AGENTS
#75Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
#76Alkylidene phosphonate esters as p-glycoprotein inducers
#77Stable peptide-conjugated ascorbic acid derivative, method for preparing same, and cosmetic composition comprising same
#78Monomers and oligonucleotides comprising cycloaddition adduct(s)
#79KLK4 inhibitors
#80Prodrug compounds and their uses
#81Ferrocene-based compounds and palladium catalysts based thereon for the alkoxycarbonylation of ethylenically unsaturated compounds
#82Ferrocene-based compounds and palladium catalysts based thereon for the alkoxycarbonylation of ethylenically unsaturated compounds
#83Phosphine ligand and palladium catalysts based thereon for the alkoxycarbonylation of ethylenically unsaturated compounds
#84Monophosphine compounds and palladium catalysts based thereon for the alkoxycarbonylation of ethylenically unsaturated compounds
#85Benzene-based diphosphine ligands for alkoxycarbonylation
#86Substituted bisphenyl butanoic phosphonic acid derivatives as NEP inhibitors
#87Nucleic acid prodrugs and methods of use thereof
#88Hydroxy formamide derivatives and their use
#89Ligand compound, catalyst system for olefin oligomerization, and method for olefin oligomerization using the same
#90Ligand compound, catalyst system for olefin oligomerization, and olefin oligomerization method using the same
#91Triarylphosphine or triarylarsine compound, alpha-olefin polymerization catalyst using the compound, ternary copolymer, and production process of alpha-olefin-((meth)acrylic acid)-based copolymer
#92Catalytic enantioselective synthesis of 2-aryl chromenes and related phosphoramidite ligands and catalyst compounds
#93Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
#94Antibody-nanoparticle conjugates and methods for making and using such conjugates
#95Monomers and oligonucleotides comprising cycloaddition adduct(s)
#96Synthetic Polymers Containing Amino Acid Side Chains
#97Substituted bisphenyl butanoic phosphonic acid derivatives as NEP inhibitors
#98Ligand compound, catalyst system for olefin oligomerization, and method for olefin oligomerization using the same
#99Catalytic enantioselective synthesis of 2-aryl chromenes and related phosphoramidite ligands and catalyst compounds
#100Process for the preparation of acylphosphanes
#101Bifunctional organic catalysts
#102Functionalized ionic liquid electrolytes for lithium ion batteries
#103ASCORBIC ACID-RELATED COMPOUND AND PLANT ANTIVIRAL AGENT
#104Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
#105ANDROGRAPHOLIDE ANALOGS AND THEIR USE FOR MEDICATION
#106METHOD OF PROVIDING PLANT WITH STRESS RESISTANCE
#107Protected fluorescent reagent compounds
#108Ascorbic acid derivative composition and production method of the same, ascorbic acid derivative solution, and skin external preparation
#109NOVEL POLYMORPHS OF FOSAMPRENAVIR CALCIUM
#110Antiviral phosphonate analogs
#111Heteroarylcarboxylic acid ester derivative
#112Phosphine ligands for catalytic reactions
#113Process for preparation of substantially pure fosamprenavir calcium and its intermediates
#114Ionic tags for synthesis of oligoribonucleotides
#115Substituted bisphenyl butanoic phosphonic acid derivatives as NEP inhibitors
#116Compounds as receptor modulators with therapeutic utility
#117Process for making novel chiral phosphorus ligands
#118ALLENE DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS
#119Compounds as receptor modulators with therapeutic utility
#120Heteroarylcarboxylic acid ester derivative
#121Compounds as receptor modulators with therapeutic utility
#122Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
#123Diamino acid derivative starting material, manufacturing method thereof, and diamino acid derivative manufacturing method
#124Crystalline fosamprenavir calcium and process for the preparation thereof
#125Phenyl-substituted bicyclooctane-1,3-dione-derivatives
#126PREPARATION METHOD OF FOSAMPRENAVIR DERIVATIVES AND RELEVANT INTERMEDIATE THEREOF
#127NOVEL PROCESS FOR THE PREPARATION OF (3S)-TETRAHYDROFURAN-3-YL (IS, 2R)-3-[[(4-AMINOPHENYL) SULFONYL] (ISOBUTYL) AMINO]-1-BENZYL-2-(PHOSPHONOOXY) PROPYLCARBAMATE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
#128Compounds as receptor modulators with therapeutic utility
#129Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators
#130Monomers and oligonucleotides comprising cycloaddition adduct(s)
#131Antibody-nanoparticle conjugates and methods for making and using such conjugates
#132Process for the reduction of a tertiary phosphine oxide to the corresponding tertiary phosphine in the presence of a catalyst and use of a tertiary phosphine for reducing a tertiary phosphine oxide in the presence of a catalyst
#133PROSTATE SPECIFIC MEMBRANE ANTIGEN INHIBITORS
#134Nucleic acid prodrugs and methods of use thereof
#135Heteroarylcarboxylic acid ester derivative
#136Salts of prodrugs of piperazine and substituted piperidine antiviral agents
#137Process for the preparation of fosamprenavir calcium
#138CRYSTALLINE FORM OF FOSAMPRENAVIR CALCIUM
#139Functionalized polymers
#140Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators
#141Polypeptide immobilization
#142Rare-earth complex and uses thereof
#143AMORPHOUS FOSAMPRENAVIR CALCIUM
#144Compounds as receptor modulators with therapeutic utility
#145Functionalized ionic liquid electrolytes for lithium ion batteries
#146METAL COMPLEX HAVING AROMATIC RING LIGAND CONTAINING NITROGEN ATOM
#147Phosphine ligands for catalytic reactions
#148ANTI-BACTERIAL COMPOSITIONS AND METHODS INCLUDING TARGETING VIRULENCE FACTORS OF STAPHYLOCOCCUS AUREUS
#149ANTIVIRAL PHOSPHONATE ANALOGS
#150Triarylphosphine or triarylarsine compound, alpha-olefin polymerization catalyst using the compound, ternary copolymer, and production process of alpha-olefin-((meth)acrylic acid)-based copolymer
#151PREPARATION OF FOSAMPRENAVIR CALCIUM
#152Compounds as receptor modulators with therapeutic utility
#153Method for producing organic compound and organic compound obtained by the method
#154SOLID STATE FORMS OF FOSAMPRENAVIR CALCIUM SALT AND PROCESSES FOR PREPARATION THEREOF
#155Compounds as receptor modulators with therapeutic utility
#156Bidentate chiral ligands for use in catalytic asymmetric addition reactions
#157RNAi Agents Comprising Universal Nucleobases
#158Diamino acid derivative starting material, manufacturing method thereof, and diamino acid derivative manufacturing method
#159Process for production of phosphine derivative from phosphine oxide derivative
#160BISPHOSPHONATE-PROSTATIC ACID PHOSPHATASE INHIBITOR CONJUGATES TO TREAT PROSTATE CANCER BONE METASTASIS
#161PREPARATION OF OSELTAMIVIR PHOSPHATE (TAMIFLU®) AND INTERMEDIATES STARTING FROM D-GLUCOSE OR D-XYLOSE
#162PROCESS AND INTERMEDIATES FOR THE PREPARATION OF SUBSTITUTED 1,3-OXATHIOLANES, ESPECIALLY LAMIVUDINE
#163HIV Protease Inhibiting Compounds
#164Prodrugs and conjugates of prenylation inhibitors
#165Functionalized ionic liquids, and methods of use thereof
#166Prodrugs of piperazine and substituted piperidine antiviral agents
#167SYNTHESIS OF RESOLVINS AND INTERMEDIATES, COMPOUNDS PREPARED THEREBY, AND USES THEREOF
#168Functionalized Ionic Liquids, and Methods of Use Thereof
#169SULPHONAMIDE DERIVATIVES AS PRODRUGS OF ASPARTYL PROTEASE INHIBITORS
#170POLYMERIC NUCLEOSIDE PRODRUGS
#171Amino alcohol compounds or phosphonic acid derivatives thereof
#172Method for treating a immunology-related disease
#173Nitrons Carrying a Positive Charge and Usable in Trapping Free Radicals, Especially the Superoxide Radical
#174Oligonucleotides comprising a modified or non-natural nucleobase
#175Antiviral phosphonate analogs
#176ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS
#177NOVEL BISAMIDATE PHOSPHONATE PRODRUGS
#178Hypophosphorous Acid Derivatives and their Therapeutical Applications
#179OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM
#180DEUTERIUM-ENRICHED FOSAMPRENAVIR
#181Sphingosine-1-phosphate receptor agonist and antagonist compounds
#182Novel Phosphinic Acid-Containing Thyromimetics
#183Lysophosphatidic acid receptor selective antagonists
#184Cycloolefin phosphine ligands and their use in catalysis
#185Facilitated transport of bisphosphonates by vitamin C
#186Ascorbic acid derivatives and skin-whitening cosmetics
#187RNAi Agents Comprising Universal Nucleobases
#188Alpha-HYDROXY, alpha-SUBSTITUTED METHYLENEBISPHOSPHONATES AND PHOSPHONOACETATES
#189Photolabile compound, oligomer probe array and substrate for oligomer probe array containing the same, and manufacturing method of the same
#190Functionalized ionic liquids, and methods of use thereof
#191Method of fabricating organic thin film transistor using self assembled monolayer-forming compound containing dichlorophosphoryl group
#192Reagents useful for synthesizing rhodamine-labeled oligonucleotides
#193Polypeptide immobilization
#194Sulfonylethyl phosphorodiamidates
#195Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase
#196Lipid-Based Drug Delivery Systems Containing Unnatural Phospholipase A2 Degradable Lipid Derivatives and the Therapeutic Uses Thereof
#197Preparation of oseltamivir phosphate (Tamiflu) and intermediates starting from D-glucose or D-xylose
#198Nitrons carrying a positive charge and usable in trapping free radicals, especially the superoxide radical
#199Process for preparing acylphosphanes and derivatives thereof
#200Inhibitors of β-lactamase
#201Creatine phosphate prodrugs, compositions and uses thereof
#202Therapeutic cyclopentane derivatives
#203Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase
#204Method and compositions for identifying anti-hiv therapeutic compounds
#205Bisphosphines as bidentate ligands
#206POLYMERIC NUCLEOSIDE PRODRUGS
#207Chiral diphosphorus compounds and their transition metal complexes
#208Amino alcohol compounds or phosphonic acid derivatives thereof
#209Stabilized ascorbic acid derivative
#210Agent for skin external use containing salt of ascorbic acid derivative, method for stabilizing the agent for skin external use, and stabilizer
#211Bisphosphines as bidentate ligands
#212Amino alcohol compounds
#213Water-dispersible carotenoids, including analogs and derivatives
#214Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
#215Methods for synthesis of carotenoids, including analogs, derivatives, and synthetic and biological intermediates
#216Aryl Phosphate Derivatives of d4T
#217Ascorbic acid derivatives and skin-whitening cosmetics
#218Therapeutic phosphonate compounds
#219Anti-inflammatory phosphonate compounds
#220Method for making nitrile compounds from ethylenically unsaturated compounds
#221Non nucleoside reverse transcriptase inhibitors
#222Method and compositions for identifying anti-hiv therapeutic compounds
#223Novel inhibitors of beta-lactamase
#224Stabilized ascorbic acid derivatives
#225Oligonucleotides comprising a modified or non-natural nucleobase
#226Aryl phosphate derivatives of d4T
#227Sulfonylethyl phosphorodiamidates
#228Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
#229Dioxolane analogs for improved inter-cellular delivery
#230Phosphate/sulfate ester compounds and pharmaceutical composition for inhibiting protein interacting NIMA (PIN1)
#231Method and compositions for identifying anti-HIV therapeutic compounds
#232Amino phosphonate and amino bis-phosphonate derivatives
#233Antiviral phosphonate analogs
#234Bisphosphines as bidentate ligands
#235Prodrugs of piperazine and substituted piperidine antiviral agents
#236Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds
#237Non nucleoside reverse transcriptase inhibitors
#238Aryl fructose-1,6-bisphosphatase inhibitors
#239Phosphoramidates and methods therefor
#240Immunomodulatory compounds and methods of use thereof
#241HIV protease inhibiting compounds
#242Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
#243Method of treating a condition by administering a prostaglandin derivative
#2442-decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
#245Immunomodulatory compounds and methods of use thereof
#246Novel lysophosphatidic acid receptor agonists and antagonists
#247Chiral diphosphorus compounds and their transition metal complexes
#248Phosphorous organic compounds and their use
#249Azole or triazole derivatives, method for preparing same and use thereof as fungicides
#250Amino alcohol compounds
#251Inhibitors of β-lactamase
#252Novel bisamidate phosphonate prodrugs
#253Flame retardant materials derived from furan dicarboxylic methyl ester